HomeNAV • CVE
add
Navco Pharmaceuticals Inc
Previous close
$0.010
Year range
$0.0050 - $0.12
Market cap
570.70K CAD
Avg Volume
58.69K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 133.64K | -82.69% |
Net income | -876.64K | -165.65% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -122.27K | 84.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.35K | -96.87% |
Total assets | 75.19K | -91.93% |
Total liabilities | 931.95K | 10.37% |
Total equity | -856.76K | — |
Shares outstanding | 57.11M | — |
Price to book | -0.50 | — |
Return on assets | -65.09% | — |
Return on capital | -98.38% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -876.64K | -165.65% |
Cash from operations | -25.87K | 94.30% |
Cash from investing | — | — |
Cash from financing | 22.01K | 165.20% |
Net change in cash | -3.86K | 99.21% |
Free cash flow | 31.50K | 114.36% |
About
Headquarters
Website
